In the last year, several institutions-the World Health Organization (WHO), the United Nations Office on Drugs and Crime, and the United States Institute of Medicine-have turned their attention, with varying degrees of effectiveness, to the problem of dangerously poor quality medicines While substandard medicines are found everywhere in the world, it is the poorest countries with the weakest capacity for drug regulation and quality control that suffer the most.
No takes yet. Share an insight, caveat, or question.
Binagwaho et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: